Cardioprotective and vasorelaxant effects of carvacrol: a mechanistic approach
Authors:
- Vicenilma de Andrade Martins CostaVCVicenilma de Andrade Martins Costa
- Daiane Pereira da SilvaDSDaiane Pereira da Silva
- Jhônata Costa MouraJMJhônata Costa Moura
- Carlos José Moraes DiasCDCarlos José Moraes Dias
- Herikson Araujo CostaHCHerikson Araujo Costa
- Antonio Carlos Romão BorgesABAntonio Carlos Romão Borges
- Rachel Melo RibeiroRRRachel Melo Ribeiro
Open Access
- 11 July 2024
- journal article
- research article
- Published by Revista Cientifica Multidisciplinar Nucleo Do Conhecimento in Revista Científica Multidisciplinar Núcleo do Conhecimento
- Vol. 01 (05) , 102-118
Abstract
Cardiovascular disorders are the leading cause of morbidity and mortality worldwide. Therefore, it is beneficial to investigate new therapies for the control and treatment of these disorders. In this context, carvacrol emerges as a phytochemical with important therapeutic potential. Therefore, this article aims to discuss and describe the pharmacokinetic properties and main mechanisms that explain the effects of carvacrol on cardiovascular disorders. ADMET studies revealed that carvacrol has promising pharmacodynamic characteristics for cardiovascular treatments. Some studies showed that animals treated with carvacrol had a decrease in the infarct area, less collagen deposition, lower serum concentrations of cardiac injury markers, as well as a decrease in the expression of proteins involved in cellular apoptosis pathways, evidencing its cardioprotective role. However, most of the effects described are related to intraperitoneal and intravenous treatment in normotensive animals, being limited studies that investigated the effects of carvacrol by the oral route and demonstrating the need to continuation of the works with models of spontaneous hypertension, which would better mimic the systemic arterial hypertension observed in humans.Keywords
This publication has 30 references indexed in Scilit:
- Carvacrol reduces blood pressure, arterial responsiveness and increases expression of MAS receptors in spontaneously hypertensive ratsEuropean Journal of Pharmacology, 2022
- Carvacrol protects against diabetes-induced hypercontractility in the aorta through activation of the PI3K/Akt pathwayBiomedicine & Pharmacotherapy, 2020
- Moieties of plant-derived compounds responsible for outward current production and TRPA1 activation in rat spinal substantia gelatinosaPharmacological Reports, 2019
- Effects of phytogenic feed additive based on thymol, carvacrol and cinnamic aldehyde on body weight, blood parameters and environmental bacteria in broilers chickensMicrobial Pathogenesis, 2018
- Sulfite‐free lamb burger meat: antimicrobial and antioxidant properties of green tea and carvacrolJournal of the Science of Food and Agriculture, 2018
- Carvacrol promotes angiogenic paracrine potential and endothelial differentiation of human mesenchymal stem cells at low concentrationsMicrovascular Research, 2018
- Perspectives on medicinal properties of natural phenolic monoterpenoids and their hybridsMolecular Diversity, 2017
- Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathwaysEuropean Journal of Pharmacology, 2017
- Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cellsAtherosclerosis, 2015
- Modulation of Pb(II) Caused Aortal Constriction by Eugenol and CarvacrolBiological Trace Element Research, 2014